Thalidomide

Journal of pain and symptom management

Volumn 41, Issue 1, 2011, Pages 140-145

  Prommer, Eric E ^a   Twycross, Robert ^b   Mihalyo, Mary ^c   Wilcock, Andrew ^d  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c DUQUESNE UNIVERSITY   (United States)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOLOGIC FACTOR; THALIDOMIDE;

ABNORMALITIES, DRUG-INDUCED; CARDIOVASCULAR DISEASES; CHEMICALLY INDUCED; CHRONIC DISEASE; DOSE RESPONSE; EVIDENCE BASED MEDICINE; HUMAN; INFLAMMATION; PERIPHERAL NERVOUS SYSTEM DISEASES;

ABNORMALITIES, DRUG-INDUCED; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; EVIDENCE-BASED MEDICINE; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION; PERIPHERAL NERVOUS SYSTEM DISEASES; THALIDOMIDE;

EID: 84898921920     PISSN: None     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2010.10.001     Document Type: Short Survey

References (0)